New technologies delivered to your inbox Subscribe
Browse by Collection
Browse by Category
- Information and Communications
- Physical Sciences
- Life Sciences
NUS Industry Liaison Office (ILO) is the technology translation and commercialization arm of NUS. Over the last five years, ILO has played a pivotal role in getting more than 580 patents granted and more than 60 technology-based companies being spunoff from NUS. In addition to managing and commercializing NUS’ intellectual assets, ILO leverages its deep industry knowledge and network to build strong bonds in numerous technical domains.
Technologies are searchable by category, key word, or phrase and include a detailed description of the technology, inventor and patent information, and contact information to learn more about each technology.
Our available technologies are updated periodically but please feel free contact email@example.com for additional technologies and information.
2017-149 – Industry Problem Thermal and hydraulic performances of a multichannel heat sink depend on how uniform the flow is distributed tothe channels. Flow is to be properly manifolded at the heat sink inlet to ensure a uniform distribution. For theconventional straight channel heat sink, a good manifold is supposed to deliver flow to each and every one of thechannels at equal rates. However,... Read More
2017-114 – Industry Problem Low-grade thermal energy is abundantly available from many different sources such as waste heat from industrial processes, geothermal and solar energy. Utilizing low-grade waste heat leads to increased energy efficiency and profitability while reducing greenhouse gas emissions. The existing technologies for harnessing waste heat are complex, expensive and can not utilize... Read More
2017-335 – Industry Problem 20% of the total energy consumed in developed countries is utilized for air-conditioning. Thus, especially for places experiencing warm and humid conditions, besides the huge energy bills paid by the end-users, air-conditioning equipment is responsible for enormous carbon emission. Thus, HVAC industry requires innovative solution which can substantially boost the... Read More
A Method for Predicting 3D Genome Organization (Chromatin Interactions) through Machine Learning of DNA Sequence Features
2018-031 – Market Opportunity “Epigenetics”, the study of changes caused by alteration of gene expression rather than the genetic code, has been gaining importance as a promising scientific approach for understanding complex diseases such as cancer. The pharmaceutical industry experienced considerable growth based on sales revenues of epigenetic drugs and there is increasing interest in discovering... Read More
15107a – MARKET OPPORTUNITY The global market for nasogastric (NG) tubes is expected to grow from US$224.6 million in 2016 to about US$257.9 million by 2021, with a compound annual growth rate (CAGR) of 2.81% from 2016-2021. NG intubation is most commonly used for patients who: • have neck or facial injuries • have had neck or facial surgery • need a mechanical ventilator to breathe • have an... Read More
2018-040 – MARKET OPPORTUNITY The bacteriological testing market was USD 9.58 billion in 2017, and is projected to reach USD 13.98 billion by 2022, at a compound annual growth rate of 7.8%. Culture methods require 4-5 days to obtain presumptive positive or negative results and can take up to 7 days, depending on the biochemical and serological confirmations. The current dyes used for viability PCR... Read More
2018-091 – PRODUCT NAME Anti – A antigen Antibody (CLONE 20G3) BACKGROUND INFOMATION The ABO blood group antigens remain of prime importance in transfusion medicine—they are the most immunogenic of all the blood group antigens. The most common cause of death from a blood transfusion is a clerical error in which an incompatible type of ABO blood is transfused. The ABO blood group antigens also... Read More
14175n – PRODUCT NAME Anti – CD137 Ligand BACKGROUND INFOMATION CD137 and CD137 ligand interaction is important in transplant rejection, pathogen clearance and protection against malignant diseases. The study of CD137 ligand may be used for evaluating the potential predictive and correlative functions in oncology in preclinical and clinical studies and may assist in answering certain crucial... Read More
14184n – PRODUCT NAME Anti – HepaCAM BACKGROUND INFOMATION HepaCAM (GlialCAM) is frequently deleted in carcinomas, and reintroduction of hepaCAM intotransformed cell lines reduces cellular growth and induces senescence. Mutationsin HEPACAM give rise to the neurodegenerative disease megalencephalic leukoencephalopathywith subcortical cysts (MLC) since mutated hepaCAM prevents shuttling of MLC1... Read More
15306n – MARKET OPPORTUNITY Gene therapy is considered to be a highly effective treatment for chronic diseases with minimum side effects. The global cancer gene therapy market was valued at $289 million in 2016, and is estimated to reach $2,082 million by 2023, at a compound annual growth rate of 32.4% from 2017 to 2023. TECHNOLOGY An advanced tsRNA design towards a Herpes simplex virus thymidine... Read More